These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1349525)

  • 21. Characterisation of yeast phosphoglycerate kinase modified by mutagenesis at residue 21.
    Walker PA; Joâo HC; Littlechild JA; Williams RJ; Watson HC
    Eur J Biochem; 1992 Jul; 207(1):29-37. PubMed ID: 1628654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yeast phosphoglycerate kinase: investigation of catalytic function by site-directed mutagenesis.
    Wilson CA; Hardman N; Fothergill-Gilmore LA; Gamblin SJ; Watson HC
    Biochem J; 1987 Jan; 241(2):609-14. PubMed ID: 3297036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The steady-state kinetics of yeast phosphoglycerate kinase. Anomalous kinetic plots and the effects of salts on activity.
    Scopes RK
    Eur J Biochem; 1978 Apr; 85(2):503-16. PubMed ID: 348474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proton-NMR study of a site-directed mutation (His388----Glu) in the interdomain region of yeast phosphoglycerate kinase. Implications for domain movement.
    Graham HC; Williams RJ; Littlechild JA; Watson HC
    Eur J Biochem; 1991 Mar; 196(2):261-9. PubMed ID: 2007400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-directed mutations of arginine 65 at the periphery of the active site cleft of yeast 3-phosphoglycerate kinase enhance the catalytic activity and eliminate anion-dependent activation.
    Sherman MA; Dean SA; Mathiowetz AM; Mas MT
    Protein Eng; 1991 Dec; 4(8):935-40. PubMed ID: 1817256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-directed mutagenesis of yeast phosphoglycerate kinase. The 'basic-patch' residue arginine 168.
    Walker PA; Littlechild JA; Hall L; Watson HC
    Eur J Biochem; 1989 Jul; 183(1):49-55. PubMed ID: 2502400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of anthraquinone dyes and evaluation of the kinetic mechanism of yeast phosphoglycerate kinase.
    Beissner RS; Rudolph FB
    J Biol Chem; 1979 Jul; 254(14):6273-7. PubMed ID: 376530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR analysis of the interdomain region of yeast phosphoglycerate kinase.
    Wilson HR; Williams RJ; Littlechild JA; Watson HC
    Eur J Biochem; 1988 Jan; 170(3):529-38. PubMed ID: 3276512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of yeast phosphoglycerate kinase by lanthanide-ATP complexes.
    Tanswell P; Westhead EW; Williams RJ
    FEBS Lett; 1974 Nov; 48(1):60-3. PubMed ID: 4609802
    [No Abstract]   [Full Text] [Related]  

  • 30. Nuclear magnetic resonance studies of isolated structural domains of yeast phosphoglycerate kinase.
    Fairbrother WJ; Minard P; Hall L; Betton JM; Missiakas D; Yon JM; Williams RJ
    Protein Eng; 1989 Oct; 3(1):5-11. PubMed ID: 2682611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Product inhibition studies of yeast phosphoglycerate kinase evaluating properties of multiple substrate binding sites.
    Schierbeck B; Larsson-Raźnikiewicz M
    Biochim Biophys Acta; 1979 May; 568(1):195-204. PubMed ID: 375985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance studies on manganese-nucleotide complexes of phosphoglycerate kinase.
    Chapman BE; O'Sullivan WJ; Scopes RK; Reed GH
    Biochemistry; 1977 Mar; 16(5):1005-10. PubMed ID: 321006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of anions, substrates, metal ions and sulfhydryl reagents on the proteolytic susceptibility of yeast phosphoglycerate kinase.
    Wrobel JA; Stinson RA
    Biochim Biophys Acta; 1981 Dec; 662(2):236-45. PubMed ID: 7032600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of phosphoglycerate kinase by salicylates.
    Larsson-Raźnikiewicz M; Wiksell E
    Biochim Biophys Acta; 1978 Mar; 523(1):94-100. PubMed ID: 343818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies with inhibitors of the glycolytic enzyme phosphoglycerate kinase for potential treatment of cardiovascular and respiratory disorders.
    Mcharg J; Littlechild JA
    J Pharm Pharmacol; 1996 Feb; 48(2):201-5. PubMed ID: 8935172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the kinetics of reversible enzyme inhibition by a general algebraic method. Application to multisite inhibition of the phosphoglycerate kinase from Trypanosoma brucei.
    Puech J; Callens M; Willson M
    J Enzyme Inhib; 1998; 14(1):27-47. PubMed ID: 10520758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-directed mutagenesis of yeast phosphoglycerate kinase. Arginines 65, 121 and 168.
    Barber MD; Gamblin SJ; Watson HC; Littlechild JA
    FEBS Lett; 1993 Apr; 320(3):193-7. PubMed ID: 8462685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 31P NMR study of bound reactants and products of yeast 3-phosphoglycerate kinase at equilibrium and the effect of sulfate ion.
    Rao BD; Cohn M; Scopes RK
    J Biol Chem; 1978 Nov; 253(22):8056-60. PubMed ID: 361736
    [No Abstract]   [Full Text] [Related]  

  • 39. Photochemically induced dynamic nuclear polarization NMR study of yeast and horse muscle phosphoglycerate kinase.
    Scheffler JE; Cohn M
    Biochemistry; 1986 Jul; 25(13):3788-96. PubMed ID: 3527256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase.
    Flachner B; Varga A; Szabó J; Barna L; Hajdú I; Gyimesi G; Závodszky P; Vas M
    Biochemistry; 2005 Dec; 44(51):16853-65. PubMed ID: 16363799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.